Ruyiping formula inhibits metastasis via the microRNA-134-SLUG axis in breast cancer
Abstract Background Metastasis is the leading cause of death among breast cancer patients. MicroRNA-134 has been reported to have a tumor-suppressive role in breast cancer. Ruyiping (RYP), a traditional Chinese formula, has been shown with the ability to reduce breast cancer metastasis in pre-clinic...
Saved in:
Main Authors: | Ziwei Jiang (Author), Lixia Pei (Author), Ying Xie (Author), Qun Ye (Author), Xiaoqiang Liang (Author), Yiyi Ye (Author), Sheng Liu (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
AntimiR targeting of microRNA-134 reduces seizures in a mouse model of Angelman syndrome
by: Aoife Campbell, et al.
Published: (2022) -
MicroRNA-134-5p Regulates Media Degeneration through Inhibiting VSMC Phenotypic Switch and Migration in Thoracic Aortic Dissection
by: Ying Wang, et al.
Published: (2019) -
MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis
by: Neha Datta, et al.
Published: (2023) -
MicroRNA-206 suppresses mesothelioma progression via the Ras signaling axis
by: Anand Singh, et al.
Published: (2021) -
MicroRNA-140 Inhibits the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer
by: Jiazhi Li, et al.
Published: (2018)